Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $81,537.77 +2.32%
Ethereum $2,308.04 +1.95%
BNB $682.38 +1.32%
Optimism $0.15 -0.90%
Arbitrum $0.13 +0.17%
Solana $93.18 +2.18%
Polygon $0.22 +2.77%
Cosmos $2.05 -0.55%
Avalanche $10.04 +2.44%

Bitcoin $81,537.77 +2.32%
Ethereum $2,308.04 +1.95%
BNB $682.38 +1.32%
Optimism $0.15 -0.90%
Arbitrum $0.13 +0.17%
Solana $93.18 +2.18%
Polygon $0.22 +2.77%
Cosmos $2.05 -0.55%
Avalanche $10.04 +2.44%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B